A carregar...
A Novel CXCR4 Antagonist CX549 Induces Neuroprotection in Stroke Brain
C-X-C chemokine receptor type 4 (CXCR4) is a receptor for a pleiotropic chemokine CXCL12. Previous studies have shown that the acute administration of the CXCR4 antagonist AMD3100 reduced neuroinflammation in stroke brain and mobilized bone marrow hematopoietic stem cells (HSCs). The purpose of this...
Na minha lista:
| Publicado no: | Cell Transplant |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5661213/ https://ncbi.nlm.nih.gov/pubmed/27938478 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3727/096368916X693563 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|